Prediction and verification of the prognostic biomarker <i>SLC2A2</i> and its association with immune infiltration in gastric cancer-Reference-Cited by-同舟云学术

Prediction and verification of the prognostic biomarker SLC2A2 and its association with immune infiltration in gastric cancer

Published:2023-12-21 Issue:2 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Weijian¹,Zhou Dishu²,Song Shuya²,Hong Xinxin³,Xu Yifei³,Wu Yuqi¹,Li Shiting¹,Zeng Sihui¹,Huang Yanzi³,Chen Xinbo³,Liang Yizhong³,Guo Shaoju³,Pan Huafeng²,Li Haiwen³

Affiliation:

1. The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518033, P.R. China

2. Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China

3. Department of Gastroenterology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518033, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference57 articles.

1. High expression of CPT1A predicts adverse outcomes: A potential therapeutic target for acute myeloid leukemia;Shi;EBiomedicine,2016

2. Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib;Granito;Ther Adv Gastroenterol,2016

3. Analysis of related risk factors and prognostic factors of gastric cancer with bone metastasis: A SEER-based study;Xiaobin;J Immunol Res,2022

4. Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study;Zhong;Front Oncol,2023

5. Prognostic biomarker HAMP and associates with immune infiltration in gastric cancer;Yang;Int Immunopharmacol,2022